134 related articles for article (PubMed ID: 6308977)
1. The role of endogenous opiates in shock: experimental and clinical studies in vitro and in vivo.
Weissglas IS
Adv Shock Res; 1983; 10():87-94. PubMed ID: 6308977
[No Abstract] [Full Text] [Related]
2. Cardiocirculatory effects of physiological doses of beta-endorphin.
Tuggle DW; Horton JW
Circ Shock; 1986; 18(3):215-25. PubMed ID: 2938843
[TBL] [Abstract][Full Text] [Related]
3. The role of endogenous opiates in the pathophysiology of hypovolemic shock and their interrelationship with the pituitary-adrenal axis.
Vargish T
Adv Shock Res; 1983; 10():57-61. PubMed ID: 6349300
[No Abstract] [Full Text] [Related]
4. Naloxone in endotoxic shock: experimental models and clinical perspective.
Gurll N
Adv Shock Res; 1983; 10():63-71. PubMed ID: 6308974
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular consequences of endogenous opiate antagonism.
Holaday JW
Biochem Pharmacol; 1983 Feb; 32(4):573-85. PubMed ID: 6299300
[No Abstract] [Full Text] [Related]
6. Naloxone: ineffective in improving cardiac performance after hypoperfusion in swine.
Heydorn WH; Moores WY; Bellamy RF; O'Benar JD
Circ Shock; 1985; 17(1):35-43. PubMed ID: 2932263
[TBL] [Abstract][Full Text] [Related]
7. The role of endogenous opiates in shock: introductory comments.
Holaday JW; Reynolds DG
Adv Shock Res; 1983; 10():53-5. PubMed ID: 6880962
[No Abstract] [Full Text] [Related]
8. Phosphodiesterase inhibition by naloxone augments the inotropic actions of beta-adrenergic stimulation.
Park WK; Chang CH; Chae JE; Kim MH; Cho YL; Ahn DS
Acta Anaesthesiol Scand; 2009 Sep; 53(8):1043-51. PubMed ID: 19572940
[TBL] [Abstract][Full Text] [Related]
9. Effects of hemorrhagic shock and endotoxin shock on plasma levels of beta-endorphin and beta-lipotropin.
Oyama T; Yao M; Ishihara H; Kudo T; Kudo M; Matsuki A
Prog Clin Biol Res; 1983; 111():185-96. PubMed ID: 6306679
[No Abstract] [Full Text] [Related]
10. The cardiovascular actions of morphine and the endogenous opioid peptides.
Johnson MW; Mitch WE; Wilcox CS
Prog Cardiovasc Dis; 1985; 27(6):435-50. PubMed ID: 2988015
[No Abstract] [Full Text] [Related]
11. Cardiovascular effects of endogenous opiate systems.
Holaday JW
Annu Rev Pharmacol Toxicol; 1983; 23():541-94. PubMed ID: 6307129
[No Abstract] [Full Text] [Related]
12. Naloxone without transfusion prolongs survival and enhances cardiovascular function in hypovolemic shock.
Gurll NJ; Reynolds DG; Vargish T; Lechner R
J Pharmacol Exp Ther; 1982 Mar; 220(3):621-4. PubMed ID: 7062272
[TBL] [Abstract][Full Text] [Related]
13. Late administration of methylprednisolone does not enhance naloxone effect in hypovolemic shock.
Beamer KC; Daly T; Vargish T
Circ Shock; 1986; 19(2):221-30. PubMed ID: 3719922
[TBL] [Abstract][Full Text] [Related]
14. Endorphins and memory regulation.
Izquierdo I; Netto CA; Dias RD
NIDA Res Monogr; 1986; 70():237-54. PubMed ID: 2945114
[No Abstract] [Full Text] [Related]
15. Failure of naloxone or beta-endorphin to affect pressure-induced tremor in guinea pig.
Gilman SC; Ackerman MJ; Hallenbeck JM; Faden A
Undersea Biomed Res; 1983 Jun; 10(2):89-93. PubMed ID: 6310841
[TBL] [Abstract][Full Text] [Related]
16. Peripheral effects of opiate antagonists in shock.
Lefer AM; Curtis MT
Adv Shock Res; 1983; 10():83-6. PubMed ID: 6308976
[No Abstract] [Full Text] [Related]
17. Opiate antagonists and thyrotropin-releasing hormone. I. Potential role in the treatment of shock.
Faden AI
JAMA; 1984 Sep; 252(9):1177-80. PubMed ID: 6088820
[No Abstract] [Full Text] [Related]
18. Endogenous opioid peptides: critical care implications.
Zaloga GP; Hostinsky C; Chernow B
Heart Lung; 1984 Jul; 13(4):421-30. PubMed ID: 6330001
[TBL] [Abstract][Full Text] [Related]
19. Thyrotropin-releasing hormone (TRH) and circulatory shock.
McIntosh TK; Faden AI
Circ Shock; 1986; 18(3):241-58. PubMed ID: 3084122
[TBL] [Abstract][Full Text] [Related]
20. Elevation of blood levels of beta-endorphin-like immunoreactivity in patients with shock.
Pasi A; Moccetti T; Legler M; Mueller J; Foletta D; Gramsch C; Hartmann H
Res Commun Chem Pathol Pharmacol; 1983 Dec; 42(3):509-12. PubMed ID: 6320322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
